Curevo

Developer of vaccines for the treatment of various diseases

placeSeattle, Washington, United States calendar_todayFounded 2017 groups8 employees language curevovaccine.com

Registered entities

Innovation

3 patent families — focus: Human necessities; filing pace active. Cited 8 times.

YearFilings
20253

Social engagement

Social engagement: 3.5K social following, 3 posts in the last 12 months — below the industry typical range.

Investor mix

11 investors on record; lead investors include Janus Henderson Investors, RA Capital Management, Adjuvant Capital, GC Biopharma.

Investor typeCountShare
Venture capital655%
Private equity218%
Other / undisclosed327%

Recent activity

5 Mar 2026
Event
Leerink's 2026 Global Healthcare Conference
Coming soon